Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.
Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S. Delforge M, et al. Among authors: depaus j. Hemasphere. 2022 Nov 29;6(12):e813. doi: 10.1097/HS9.0000000000000813. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36479545 Free PMC article. No abstract available.
Unexpected Leishmania in a bone marrow aspirate.
Pouplard M, Timmery E, Depaus J, Denis O, Jacqmin H, Bain BJ. Pouplard M, et al. Among authors: depaus j. Am J Hematol. 2021 Sep 1;96(9):1176-1177. doi: 10.1002/ajh.26158. Epub 2021 Mar 30. Am J Hematol. 2021. PMID: 33719072 Free article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36164077
[Erythema and blood abnormality].
Perlot Q, Cabo J, Jacqmin H, Depaus J. Perlot Q, et al. Among authors: depaus j. Rev Med Interne. 2023 Jan;44(1):38-39. doi: 10.1016/j.revmed.2022.09.006. Epub 2022 Oct 1. Rev Med Interne. 2023. PMID: 36192236 French. No abstract available.
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.
Lesokhin AM, Tomasson MH, Arnulf B, Bahlis NJ, Miles Prince H, Niesvizky R, Rodrίguez-Otero P, Martinez-Lopez J, Koehne G, Touzeau C, Jethava Y, Quach H, Depaus J, Yokoyama H, Gabayan AE, Stevens DA, Nooka AK, Manier S, Raje N, Iida S, Raab MS, Searle E, Leip E, Sullivan ST, Conte U, Elmeliegy M, Czibere A, Viqueira A, Mohty M. Lesokhin AM, et al. Among authors: depaus j. Nat Med. 2023 Sep;29(9):2259-2267. doi: 10.1038/s41591-023-02528-9. Epub 2023 Aug 15. Nat Med. 2023. PMID: 37582952 Free PMC article. Clinical Trial.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial.
Perrot A, Touzeau C, Lambert J, Hulin C, Caillot D, Karlin L, Arnulf B, Rey P, Garderet L, Macro M Dr, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano de Colella JM, Tiab M, Mohty M, Kuhnowski F, Fontan J, Manier S, Orsini Piocelle F, Vincent L, Rigaudeau S, Leleu X, Hébraud B, Flet L, Malfuson JV, Jacquet C, Chaoui D, Meuleman N, Abarah W, Montes L, Benramdane R, Sonntag C, Zerazhi H, Danu A, Allangba O, Dib M, Roussel M, Cereja S, Depaus J, Branche N, Demarquette H, Richez V, Bruiec C, Frenzel L, Vekemans MM, Bigot N, Avet-Loiseau H, Corre J, Moreau P. Perrot A, et al. Among authors: depaus j. Blood. 2025 Jan 22:blood.2024026230. doi: 10.1182/blood.2024026230. Online ahead of print. Blood. 2025. PMID: 39841461
Salvage monotherapy with venetoclax after failure from a single course of standard induction chemotherapy for acute myeloid leukaemia.
Sansen PY, Graux C, Sonet A, André M, Doyen C, Collinge E, Vellemans H, Bernard W, Crochet G, Devreux J, Depaus J, Devalet B, Desquesnes F, Pouplard M, Dachy F. Sansen PY, et al. Among authors: depaus j. Br J Haematol. 2025 Jan;206(1):361-364. doi: 10.1111/bjh.19906. Epub 2024 Nov 26. Br J Haematol. 2025. PMID: 39592448 No abstract available.
13 results